Pharmesis International Ltd. (SGX:BFK)
Singapore
· Delayed Price · Currency is SGD 0.355
0.00 (0.00%)
Last updated: Apr 27, 2026, 9:00 AM SGT
Pharmesis International Revenue
In the year 2025, Pharmesis International had annual revenue of 43.75M CNY, down -35.32%. Pharmesis International had revenue of 16.55M in the half year ending December 31, 2025, a decrease of -7.74%.
Revenue
43.75M CNY
Revenue Growth
-35.32%
P/S Ratio
1.40
Revenue / Employee
39.92K CNY
Employees
1,096
Market Cap
11.25M SGD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.75M | -23.90M | -35.32% |
| Dec 31, 2024 | 67.65M | 22.01M | 48.24% |
| Dec 31, 2023 | 45.64M | -4.73M | -9.40% |
| Dec 31, 2022 | 50.37M | -2.40M | -4.55% |
| Dec 31, 2021 | 52.77M | 5.66M | 12.01% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sakae Holdings | 11.92M |
| Travelite Holdings | 37.83M |
| Ouhua Energy Holdings | 399.19M |
| IPC Corporation | 1.92M |
| Acma Ltd. | 7.94M |
| Ascent Bridge | 1.57M |
| AMOS Group | 47.06M |
| Captii | 15.94M |